Home › Ictus ischemico › New York › New York City
Studi clinici su Ictus ischemico a New York City, NY
17 studi su Ictus ischemico cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
In reclutamentoFase 3
- Mount Sinai Hospital, New York
Strategy for Improving Stroke Treatment Response
In reclutamentoFase 2
- The Mount Sinai Hospital, New York
- NYP Columbia University Medical Center, New York
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
In reclutamentoFase 3
- NYU Langone Health, New York
- Columbia University Medical Center, New York
- Weill Medical College of Cornell University, New York
Continuous Dual Aspiration Technique With Zoom System for Stroke
In reclutamentoStudio osservazionale
- Icahn School of Medicine at Mount Sinai, New York
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
In reclutamentoFase 2/3
- Corxel Investigational Site, New York
The Fourth Left Atrial Appendage Occlusion Study
In reclutamento
- Cornell University for and on behalf of its Joan & Sanford I. Weill Medical College and The New York Presbyterian Hospital, New York
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
In reclutamentoFase 2/3
- Northwell Health Physician Partners - Neurology at Lenox Hill, New York
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
In reclutamentoStudio osservazionale
- Icahn School of Medicine at Mount Sinai, New York
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
In reclutamentoStudio osservazionale
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
In reclutamentoStudio osservazionale
- The Mount Sinai Hospital, New York
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
In reclutamento
- Weill Cornell Medical Center, New York
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study
In reclutamento
- Columbia University Medical Center/ NewYork Presbyterian Hospital, New York
The Pivotal Study of RapidPulseTM Aspiration System
In reclutamento
- Icahn School of Medicine at Mount Sinai, New York
Vivistim Registry for Paired VNS Therapy (GRASP)
In reclutamentoStudio osservazionale
- Mt. Sinai, New York
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
In reclutamento
- New York Presbyterian - Weill Cornell Hospital, New York
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
In reclutamento
- The Research Foundation for SUNY on behalf of University at Buffalo, New York
StrokeNet Thrombectomy Endovascular Platform
In reclutamento
- The Mount Sinai Hospital, New York
Studi su Ictus ischemico in altre città
- Houston, TX18 studi
- Boston, MA16 studi
- Los Angeles, CA14 studi
- Atlanta, GA13 studi
- Chicago, IL12 studi
- Philadelphia, PA12 studi
- Cincinnati, OH11 studi
- Pittsburgh, PA11 studi
- St. Louis, MO11 studi
- Salt Lake City, UT10 studi
- Baltimore, MD10 studi
- Charlottesville, VA9 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.